Carregant...
Biometals and Their Therapeutic Implications in Alzheimer’s Disease
No disease modifying therapy exists for Alzheimer’s disease (AD). The growing burden of this disease to our society necessitates continued investment in drug development. Over the last decade, multiple phase 3 clinical trials testing drugs that were designed to target established disease mechanisms...
Guardat en:
| Publicat a: | Neurotherapeutics |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4322070/ https://ncbi.nlm.nih.gov/pubmed/25354461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-014-0312-z |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|